Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. PINK: which is better?

Bottom line

PRHSX vs PINK: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and PINK (Simplify Health Care ETF) share a meaningful slice of their top holdings — about 41% by weight.

But PRHSX is far broader, holding 279 positions to 54 for PINK, so beyond the top names it adds exposure PINK doesn't have.

PINK is cheaper at 0.51% vs 0.83% — a difference of $32 a year per $10,000 invested.

Over one year, PINK returned +24.1% vs +17.7% for PRHSX.

Updated Nov 19, 2026

PRHSX vs PINK side by side

PRHSXPINK
TypeMutual fundETF
Fund familyT. Rowe PriceSimplify Exchange Traded
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%0.51%
Annual cost per $10k$83$51
10-yr cost on $10k (prospectus)$1,025$641
Max front load—None
12b-1 fee—0%
1-yr return+17.7%+24.1%
5-yr return (annualized)+4.2%—
10-yr return (annualized)+9.1%—
Best quarter+23.5%+15.6%
Worst quarter−15.8%−9.5%
Net assets (fund)$11.9B$358.6M
Number of holdings27954
Portfolio turnover62%171%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPRHSXPINKDifference
2025+17.7%+24.1%−6.4%
2024+1.8%+8.9%−7.1%
2023+3.1%+3.8%−0.7%
2022−12.2%−4.3%−7.9%

Source: Fund prospectus bar charts

Holdings overlap

12 of PRHSX's top 25 holdings also appear in PINK's top 25.

Shared top holdings
HoldingPRHSXPINK
Eli Lilly & Co14.28%5.91%
Johnson & Johnson6.63%5.45%
Unitedhealth Group Inc5.99%5.76%
Abbvie Inc5.10%4.52%
Gilead Sciences Inc2.82%2.87%
Thermo Fisher Scientific Inc2.52%3.23%
Vertex Pharmaceuticals Inc2.28%1.45%
Amgen Inc1.82%2.12%
Elevance Health Inc1.53%2.73%
Danaher Corp1.43%2.28%
Cardinal Health Inc1.03%1.78%
Cvs Health Corp0.94%2.01%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

PINK top 10

  1. Purecycle Technologies Inc — 6.89%
  2. United Therapeutics Corp — 6.86%
  3. Novo Nordisk A/s — 6.75%
  4. Eli Lilly & Company — 5.91%
  5. Unitedhealth Group Inc — 5.76%
  6. Warby Parker Inc — 5.46%
  7. Johnson & Johnson — 5.45%
  8. Jazz Pharmaceuticals Plc — 4.61%
  9. Abbvie Inc — 4.52%
  10. Biohaven Ltd — 4.32%

FAQ

What is the difference between PRHSX and PINK?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and PINK (Simplify Health Care ETF) share a meaningful slice of their top holdings — about 41% by weight. But PRHSX is far broader, holding 279 positions to 54 for PINK, so beyond the top names it adds exposure PINK doesn't have.
Which is cheaper, PRHSX or PINK?
PINK has the lower expense ratio (0.51%).
Should I own both PRHSX and PINK?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.